Late relapses in primary CNS lymphoma after complete remissions with high-dose methotrexate monotherapy

Treatment of patients with newly diagnosed primary CNS lymphomas using high dose methotrexate regimens is reported to yield about 30% long term survivors with minimal neurotoxicity. As in other systemic large cell lymphomas, it is generally assumed that most relapses occur within 5 years of diagnosi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:CNS Oncol
Egile Nagusiak: Ambady, Prakash, Holdhoff, Matthias, Bonekamp, David, Wong, Fay, Grossman, Stuart A
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Future Medicine Ltd 2015
Gaiak:
Case Series
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4834699/
https://ncbi.nlm.nih.gov/pubmed/26507609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cns.15.34
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak